PubMed ID:
32506513
Public Release Type:
Journal
Publication Year: 2020
DOI:
https://doi.org/10.1111/jgh.15131
Authors:
Gurka Matthew J., Mack Jasmine A., Chi Xiaofei, DeBoer Mark D.
Request IDs:
22055
Studies:
The Nonalcoholic Steatohepatitis Research Network (NASH CRN) Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis
Non-alcoholic steatohepatits (NASH), which can lead to liver failure, requires liver biopsies to follow and is difficult to treat. Our goal was to assess metabolic syndrome (MetS) severity as a predictor of treatment success and a marker of response.